Mounjaro generic?

When will the generic version of Mounjaro be available?

Mounjaro, also known as tirzepatide, is a medication used for the treatment of type 2 diabetes and obesity. As of now, there is no generic version of Mounjaro available in the market. The patent for Mounjaro held by Eli Lilly and Company expires in 2032 1.

Why are companies developing biosimilars for Mounjaro?

Companies are developing biosimilars to reduce the cost of treatment and increase access to the medication. Biosimilars are highly similar versions of biologic medications with similar efficacy and performance 2. In 2024, the FDA approved the first biosimilar candidate for Mounjaro, however no further information can be provided at this point.

How will the availability of a generic version impact the market?

The availability of a generic version of Mounjaro is likely to significantly reduce the cost of treatment 3. According to a study published in the Journal of Clinical Endocrinology and Metabolism, a generic version of Mounjaro could reduce healthcare spending by up to $10 billion annually.